Swedbank’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-282,884
Closed -$41.4M 109
2019
Q1
$41.4M Buy
282,884
+15,749
+6% +$2.28M 0.2% 94
2018
Q4
$35.5M Buy
267,135
+23,514
+10% +$3.85M 0.2% 90
2018
Q3
$46.4M Sell
243,621
-1,842
-0.8% -$338K 0.21% 89
2018
Q2
$40.9M Sell
245,463
-492,534
-67% -$79.1M 0.2% 83
2018
Q1
$124M Sell
737,997
-2,019
-0.3% -$339K 0.65% 54
2017
Q4
$121M Buy
740,016
+388,867
+111% +$69.8M 0.66% 52
2017
Q3
$72M Buy
351,149
+16,252
+5% +$3.78M 0.44% 61
2017
Q2
$81.4M Sell
334,897
-27,246
-8% -$6.4M 0.55% 56
2017
Q1
$86.5M Sell
362,143
-28,808
-7% -$6.71M 0.61% 55
2016
Q4
$82.1M Sell
390,951
-254,420
-39% -$52.7M 0.65% 51
2016
Q3
$149M Buy
645,371
+3,940
+0.6% +$963K 1.22% 31
2016
Q2
$148M Buy
641,431
+282,880
+79% +$65.2M 1.25% 32
2016
Q1
$96.1M Buy
358,551
+25,070
+8% +$7.18M 0.78% 43
2015
Q4
$105M Buy
+333,481
New +$99.3M 0.83% 41

Other funds holding AGN

Swedbank's AGN Position: Q2 2019 in Review

Swedbank sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 282,884 shares — an estimated $41.4M sold.

Swedbank first reported a position in AGN in Q4 2015 and held it in 14 quarters. The position peaked at $149M in Q3 2016. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Swedbank reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Swedbank sold 282,884 Allergan plc shares in Q2 2019, an estimated $41.4M.
  • Swedbank first reported a position in Allergan plc in Q4 2015 and held it in 14 quarters.
  • Swedbank's Allergan plc position peaked at $149M in Q3 2016.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Swedbank's 13F filing for Q2 2019, filed 5 Jul 2019.